• Overview
  • Eligibility
  • More info
  • Locations

Observatoire Brestois Des Néoplasies Myéloprolifératives (NCT02897297)

All patients diagnosed or followed in Brest University Hospital for Philadelphia negative MPNs will be included in this observational study. MPNs recorded included: polycythemia vera (PV), essential Thrombocythemia (ET) and Primary Myelofibrosis (PMF). This is a not interventional study. Alive patients need to sign a non-opposition consent form. Patients will be followed until last news (death, change of reference centre...).
Ages eligible for Study
all
Genders eligible for Study
All
Accepts Healthy Volunteers
No
In this retrospective and prospective study, clinical and biological data from diagnosis until last news will be recorded.

Clinical data collected: patients and disease characteristics at the time of the diagnosis, disease and mutational status, cardio-vascular risk factors, history of thrombosis and cancer.

Biological data collected: hemogram and bone marrow results if available. During the follow-up new data will be noted: treatment changes (reasons of change and type of drug), thrombotic events (localization, date and hemogram), phenotypic evolutions (type and date), death (date and etiology).

1 locations

France (1)
  • CHRU de Brest
    recruiting
    Brest, France, 29609
Status:
recruiting
Type:
Observational
Phase:
-
Start:
31 August, 2015
Updated:
06 September, 2016
Participants:
1000
Apply
A girl giving information about available additional trials.

FindMeCure helps you find, understand and join clinical trials from all over the world.

There are more clinical trials for your condition!